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The Pin2/TRF1-Interacting Protein PinX1
Is a Potent Telomerase Inhibitor
Nakamura et al., 1997). Expression of hTERT prevents
telomere erosion and senescence in some human cells
(Bodnar et al., 1998; Vaziri and Benchimol, 1998; Kiyono
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et al., 1998). Telomerase activity is readily detected inDepartment of Medicine
most human tumor tissues and immortalized and/orBeth Israel Deaconess Medical Center
transformed cell lines (Broccoli et al., 1995; Counter etHarvard Medical School
al., 1992; Hahn et al., 1999b; Kim et al., 1994; Taylor et330 Brookline Avenue, HIM 1047
al., 1996; Meyerson et al., 1997). Furthermore, it is criticalBoston, Massachusetts 02215
for cells to escape from crisis and for transforming pri-
mary human cells (Bodnar et al., 1998; Girardi et al.,
1965; Hahn et al., 1999a; Halvorsen et al., 1999; VaziriSummary
and Benchimol, 1988). Conversely, inhibition of te-
lomerase function shortens telomeres and forces trans-Telomerase activity is critical for normal and trans-
formed cells to enter crisis (Feng et al., 1995; Hahn etformed human cells to escape from crisis and is impli-
al., 1999b; Herbert et al., 1999; Zhang et al., 1999). Genecated in oncogenesis. Here we describe a novel Pin2/
knockout experiments also reveals an essential role ofTRF1 binding protein, PinX1 that inhibits telomerase
telomerase in highly proliferative organs in mice (Blascoactivity and affects tumorigenicity. PinX1 and its small
et al., 1997; Lee et al., 1998). Finally, hTERT transcriptionTID domain bind the telomerase catalytic subunit
is regulated by oncogenic proteins such as c-Myc andhTERT and potently inhibit its activity. Overexpression
E6 (Wang et al., 1998; Wu et al., 1999; Klingelhutz et al.,of PinX1 or its TID domain inhibits telomerase activity,
1996). These results indicate that telomerase activity isshortens telomeres, and induces crisis, whereas
critical for life span of primary and transformed humandepletion of endogenous PinX1 increases telomerase
cells.activity and elongates telomeres. Depletion of PinX1
Compelling evidence indicates that the ability of te-also increases tumorigenicity in nude mice, consistent
lomerase to elongate telomeres is regulated by otherwith its chromosome localization at 8p23, a region
factors. In yeast a number of telomere proteins such aswith frequent loss of heterozygosity in a number of
RAP1, Taz1, and Cdc13 influence telomere maintenancehuman cancers. Thus, PinX1 is a potent telomerase
(Conrad et al., 1990; Cooper et al., 1997; Evans andinhibitor and a putative tumor suppressor.
Lundblad, 1999; Lustig et al., 1990). The helicase Pif1p
binds telomere DNA and inhibits telomerase-mediatedIntroduction
telomere lengthening in yeast, suggesting that Pif1 may
function as a telomerase inhibitor although its effect onTelomerase plays a crucial role in maintaining telomere
telomerase activity has not yet been shown (Zhou et al.,length and is implicated in aging and cancer (reviewed
2000a). In mammals, the telomere protein Pin2/TRF1,by Artandi and DePinho, 2000; McEachern et al., 2000;
its interacting proteins, tankyrase and Tin2, and hetero-Shay and Wright, 2001; Stewart and Weinberg, 2000).
geneous nuclear ribonucleoproteins such as A1 influ-Telomeres consist of simple DNA repeats and associ-
ence telomere length (LaBranche et al., 1998; Kim et al.,ated proteins. The function of telomeres includes main-
1999; Smith et al., 1998; van Steensel and de Lange,taining genomic stability and allowing cells escaping
1997). However, since none of these and other te-from crisis. Most normal human cells have a defined
lomerase- or telomere-associated proteins directly af-
lifespan (Hayflick and Moorhead, 1961) and do not have
fects telomerase activity, the in vivo route for regulation
telomerase activity (Broccoli et al., 1995; Taylor et al.,
of telomerase activity is unknown.
1996). Their telomeres undergo shortening following We isolated a telomere binding protein Pin2 as one
each cell division due to the “end-replication problem” of three proteins Pin1–3 that are involved in mitotic regu-
(Cooke and Smith, 1986; Harley et al., 1990; Hastie et lation (Lu et al., 1996). Pin2 is identical to TRF1 with the
al., 1990). When telomere length reaches a critical point, exception of a 20 amino acid (aa) internal deletion but
senescence is believed to occur (Cooke and Smith, is more abundant than TRF1 in cells (Shen et al., 1997);
1986; Harley et al., 1990; Hastie et al., 1990; Vaziri et al., TRF1 and Pin2 are likely generated from the same gene
1994). PIN2/TRF1 (Young et al., 1997). For clarity, we shall use
Consistent with these observations, any mechanism Pin2 for the 20 aa deleting isoform and TRF1 for the 20
that restores and/or maintains telomeres is thought to aa containing isoform (Chong et al., 1995; Lu et al., 1996),
be important for cellular immortalization and transfor- but refer to endogenous proteins as Pin2/TRF1. We have
mation (Artandi and DePinho, 2000; McEachern et al., shown that Pin2/TRF1 affects mitotic regulation and its
2000; Shay and Wright, 2001; Stewart and Weinberg, levels are altered in human breast tumor samples (Kishi
2000). The telomeric DNA sequences can be replenished et al., 2001a). Furthermore, Pin2/TRF1 is an ATM kinase
by telomerase, which contains the catalytic subunit substrate important for maintaining the mitotic check-
hTERT and the RNA component TR (Counter et al., 1997; point in response to DNA damage and is involved in the
Greider and Blackburn, 1985, 1989; Lingner et al., 1997; mitotic spindle checkpoint (Kishi et al., 2001b; Naka-
mura et al., 2001). These results indicate that Pin2/TRF1
is involved in mitotic regulation and telomere mainte-1Correspondence: klu@caregroup.harvard.edu
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tains no known domain structure except an N-terminal
Gly-rich patch (Figure 1B) (Aravind and Koonin, 1999).
The mouse PINX1 cDNA cloned by PCR encoded a pro-
tein 74% identical to the human protein (Figure 1C).
A GenBank database search revealed the presence of
PinX1 ORFs in other eukaryotic cells, including yeast
and C. elegans, which have an overall 50% similarity
to the human protein (Figure 1C), suggesting a conserva-
tion of PinX1 proteins.
To verify that the PINX1 cDNA encodes a full-length
protein, we first performed Northern analysis and a sin-
gle 1.9 kb PINX1 mRNA transcript was detected in all
16 human adult tissues examined (Supplemental Figure
S1A at http://www.cell.com/cgi/content/full/107/3/347/
DC1). We next raised anti-PinX1 antibodies, which rec-
ognized a single 45 kDa protein in HeLa cell extracts
both in immunoprecipitation and immunoblot analyses
(Supplemental Figure S1B; Figures 4A and 4B). This 45
kDa protein was shown to be PinX1 by expression of HA-
tagged PinX1 (50 kDa), followed by immunoblotting
analysis with anti-PinX1 or anti-HA antibodies (Supple-
mental Figures S1C and S1D; Figure 4A). These results
indicate that PINX1 encodes a 45 kDa protein in cells.
PinX1 Interacts with Pin2 In Vivo and In Vitro
To confirm the PinX1 and Pin2 interaction, we first per-
formed coimmunoprecipitation and colocalization ex-
periments. When cells were cotransfected with PinX1
and Pin2 expression constructs and subjected to immu-
noprecipitation, Pin2 was detected in anti-PinX1 immu-
noprecipitates, but not in the preimmune control (Figure
2A), indicating that PinX1 interacts with Pin2/TRF1 in
cells. When cells were cotransfected with GFP-PinX1
and RFP-Pin2 and their subcellular localization exam-
ined directly, PinX1 colocalized with Pin2 in the nucleus,Figure 1. Identification of Human and Mouse PINX1Genes
especially in nucleoli and at telomere speckles (Figure(A and B) Amino acid sequence and domain structure of human
2B) (Chong et al., 1995; Kishi et al., 2001b; Shen et al.,PinX1. Human PinX1 contains an N-terminal a Gly-rich region and
1997). Thus, PinX1 and Pin2/TRF1 coimmunoprecipitatea C-terminal TID domain (telomerase inhibitory domain).
(C) Sequence alignment of PinX1s from human (Hs) and mouse (Mm) and colocalize in cells.
and ORFs present in Caenorhabditis elegans (Ce) and Saccharo- We further determined their in vitro interaction using
myces cerevisiae (Sc). Black boxes with white letters highlight identi- GST pulldown experiments (Lu et al., 1999b; Shen et al.,
cal or conserved residues.
1998). GST-Pin2, but not GST, precipitated HA-PinX1
from cell extracts (Figure 2C). Conversely, PinX1, but not
GST, precipitated in vitro synthesized [35S]-Pin2 (Figurenance. To further elucidate Pin2/TRF1 function, we em-
2D). These results indicate that PinX1 interacts with Pin2ployed a two-hybrid screen and identified six known and
in vitro. To map the region in PinX1 that interacts withfour unknown genes (PinX1-4), whose products interact
Pin2, we expressed different PinX1 fragments in HeLawith Pin2. Our results demonstrate that PinX1 is a potent
cells as GFP fusion proteins (Figure 2E), and subjectedtelomerase inhibitor and a putative tumor suppressor.
them to GST pulldown experiments. GST-Pin2 bound
PinX1, its C-terminal 142–328 and 254–328 fragments,Results
but not its N-terminal 142 fragment (Figure 2F), indicat-
ing that Pin2 binds the C-terminal 74 aa of PinX1. WeIdentification of PINX1
referred the N-terminal 142 and C-terminal 74 aa frag-To identify Pin2/TRF1-interacting proteins, we screened
ments of PinX1 as PinX1-N and PinX1-C, respectivelya human HeLa cell yeast two-hybrid cDNA library using
(Figure 2E).Pin2 as bait (Lu et al., 1996). Out of 108 clones screened,
we obtained 274 strongly positive clones and identified
six known genes and four unknown genes (PinX1-4). Overexpression of PinX1 or PinX1-C in HT1080
Cells Induces CrisisThe known genes included Pin2 (2 clones), nm23-H1
(11), and Tin2 (5). The fact that Pin2/TRF1 forms dimers Pin2/TRF1, tankyrase, and Tin2 regulate telomere length
in telomerase-positive fibrosarcoma cell line HT1080(Bianchi et al., 1997; Shen et al., 1997) and interacts with
Tin2 and nm23-H1 (Kim et al., 1999; Nosaka et al., 1998) (Kim et al., 1999; Smith et al., 1998; van Steensel and
de Lange, 1997). To examine whether PinX1 affects telo-validates our screen. We here describe PinX1.
Out of three PINX1 cDNA clones, the longest one mere maintenance, we tried to establish HT1080 cell
lines stably expressing PinX1, PinX1-N, or -C. To depleteencodes a novel 328 aa protein (Figure 1A), which con-
PinX1, a Novel Telomerase Inhibitor and a Putative Tumor Suppressor
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Figure 2. Interaction between PinX1 and
Pin2/TRF1 In Vivo and In Vitro
(A) Coimmunoprecipitation of PinX1 and
Pin2/TRF1. HeLa cells were cotransfected
with PinX1 and Pin2 expression constructs
and then subjected to immunoprecipitation
with anti-PinX1 or preimmune sera, followed
by immunoblotting with anti-Pin2 antibodies.
(B) Colocalization of PinX1 with Pin2/TRF1
in cells. HeLa cells were cotransfected with
expression constructs of GFP-PinX1 and
RFP-Pin2 and subjected to fluorescence mi-
croscopy.
(C and D) Interaction of PinX1 with Pin2/TRF1
in vitro. GST or GST-Pin2 beads were incu-
bated with cell extracts containing HA-PinX1
(C) or GST or GST-PinX1 beads with synthe-
sized 35S-Pin2 (D), following by detecting
bound HA-PinX1 by immunoblot or 35S-Pin2
by autoradiography.
(E and F) Pin2/TRF1-interacting domain in
PinX1. HeLa cells transfected with various
GFP-PinX1 mutants (E) were subjected to im-
munoblotting analysis with anti-GFP antibod-
ies directly (Input) or first precipitated by GST
or GST-Pin2 beads (F).
endogenous protein, we expressed the PINX1 cDNA plains no obvious effect on the overall growth rate (Fig-
ures 3C and 3D). These results indicate that PinX1 over-in an antisense orientation (PinX1AS). Although several
clones expressing PinX1-N were obtained initially, they expression induces a fraction of cells into crisis.
The most striking phenotype was observed in PinX1-all lost expression during expansion. However, multiple
cell lines were established that stably expressed PinX1, C-expressing cells. All three PinX1-C-expressing cell
lines tested underwent crisis characterized by an overallPinX1-C, PinX1AS, or the vector (Figures 3A and 3B).
Importantly, levels of endogenous PinX1 protein were reduction in growth rate (Figures 3C and 3D). Incorpora-
tion of BrdU was significantly reduced and cells withdecreased3 fold in PinX1AS-expressing clones (Figure
3B). Therefore, we can manipulate PinX1 levels in these the G2/M DNA content increased (Figures 4A and 4B).
In some instances, reduced growth appeared to be duestable HT1080 clones.
Cells expressing PinX1AS and the control vector grew to an increased rate of cell death. Cells in this death
phase were rounded and loosely attached to culturenormally with no detectable difference in growth rate or
morphology over 60 population doublings (PD) (Figures flasks,40% of which contained a sub-G1 DNA content
(Figure 4C), a characteristic of apoptosis. However, in3C, 3D, and 4). Initially, all PinX1 or PinX1-C stable cell
lines grew at the same rates as those of control vector most cases, the cells exhibited increased size and a
flattened morphology with elongated cellular processescells (Figures 3C and 3D). However, after 20–30 PD,
the growth of PinX1-expressing cells slowed down, as and they were stained positive for the SA--Gal (Figure
4D). These results suggest that overexpression ofindicated by cell number, BrdU incorporation and cell
cycle analysis (Figures 3C, inset, 4A, and 4B). Notably, PinX1-C forces transformed cells into crisis.
on the third day after subculture when control cells
reached confluency, PinX1-expressing cells were only PinX1 Partially and PinX1-C Completely Inhibit
Telomerase Activity in Cells62% of the control (Figure 3C, inset). Interestingly, a
fraction of cells exhibited increased size and a flattened Inhibition of telomerase forces transformed cells into
crisis and telomerase activity is sufficient for transformedmorphology and also stained positively for the senes-
cence-associated -galactosidase (SA--Gal) (Figure cells to escape from crisis (Feng et al., 1995; Hahn et
al., 1999b; Halvorsen et al., 1999; Herbert et al., 1999;4D) (Dimri et al., 1995). However, other PinX1-expressing
cells were able to continue to divide and reach the con- Zhang et al., 1999). Our findings that expression of Pinx1
or PinX1-C induces crisis suggest that PinX1-C andfluency on the fourth day (Figure 3C, inset), which ex-
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Figure 3. Growth Curves of Stable Cell Lines
Expressing PinX1, PinX1-C, or PinX1AS
(A and B) Establishment of stable HT1080 cell
lines expressing PinX1 or PinX1-C or PinX1AS.
HT1080 cells were stably transfected with the
control vector (vector) or a vector expressing
HA-PinX1 or HA-PinX1-C (A) or PinX1AS (B),
followed by detecting protein expression us-
ing immunoblot.
(C–F) Growth curves of stable lines. The sta-
ble HT1080 (C and D) or GM847 (E and F) cell
lines were maintained continuously in culture,
splitting on every fourth day and seeding at
the same number of cells at each subculture.
Arrows point to PinX1-C-expressing cells that
entered crisis. (Inset in C) The cell number
was counted every day after subculture to
show the slower growth rate of PinX1-
expressing cells at 28 PD.
PinX1 might affect telomerase activity. To examine this a negative regulator of telomerase. If so, depletion of
endogenous PinX1 would result in an increase in cellularpossibility, we compared telomerase activity in stable
HT1080 cell lines. telomerase activity. To test this possibility, we assayed
telomerase activity in HT1080 cell lines that stably ex-Telomerase activity, as assayed by the standard TRAP
assay, was readily detected in vector HT1080 cell ex- pressed PinX1AS (Figure 3B). Telomerase activity in sev-
eral PinX1AS stable cell lines was significantly highertracts, but not in the extracts that were heat inactivated
or pretreated with RNase (Figure 5A, data not shown) than that in the vector-transfected cells (Figure 5). These
results indicate that depletion of endogenous PinX1 re-(Kim et al., 1999; van Steensel and de Lange, 1997).
Importantly, telomerase activity in PinX1-stable cells sults in an increase in telomerase activity in cells, further
supporting that overexpression of PinX1 inhibits te-was significantly reduced (Figure 5), indicating an inhibi-
tion of telomerase activity. Most strikingly, telomerase lomerase activity.
activity was almost not detectable in cells expressing
PinX1-C (Figure 5). Similar inhibitions on telomerase ac- Manipulation of Cellular PinX1 Function
Influences Telomere Length in HT1080 Cellstivity were also observed in other independent cell lines
examined (data not shown). These results demonstrate To confirm that PinX1 regulates cellular telomerase ac-
tivity, we measured telomere restriction fragment (TRF)that PinX1 partially and PinX1-C almost completely in-
hibit telomerase activity in cells. This difference in inhib- length in stable HT1080 cells lines. Vector control cells
maintained relatively short telomeres, with average TRFiting cellular telomerase activity correlates with their
ability to induce crisis (Figures 3 and 4). length being 4.0 kb (Figures 6A and 6C) (Kim et al.,
1999; van Steensel and de Lange, 1997). Importantly,
the same TRF length was also detected in cells stablyDepletion of Endogenous PinX1 Increases
Telomerase Activity In Vivo expressing PinX1 at early PDs, but TRF length was
slowly and progressively shortened at the late PDThe above results demonstrate that PinX1 inhibits te-
lomerase activity in vivo, suggesting that PinX1 may be (20–24 PD) (Figures 6A and 6C). The loss of telomeric
PinX1, a Novel Telomerase Inhibitor and a Putative Tumor Suppressor
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Figure 4. Overexpression of PinX1 or PinX1-C Induces Crisis
(A) Reduced DNA synthesis. Stable cell lines at 28 PD (Figure 3C) were labeled with BrdU, followed by determining BrdU incorporation using
flow cytometry.
(B and C) Cell cycle arrest and apoptosis. Attached cells at PD28 were harvested and stained with propidium iodide, followed by flow cytometry
(B). A fraction of PinX1-C expressing stable cells were rounded, which were collected and their DNA content was analyzed (C).
(D) Senescence-like morphologies. Cells at 36 PD (Figure 3C) were fixed and then subjected to senescence-associated -galactosidase (SA-
-gal) staining, followed by microscopy.
sequence was evident from the shortening of TRF length about 20 PD (Figures 6B, and 6C). Similar results were
also obtained in other independent cell lines (Supple-and from a reduction in the TTAGGG hybridization signal
(Figures 6A and 6C). However, more rapid and pro- mental Figure S2 at http://www.cell.com/cgi/content/
full/107/3/387/DC1). Significantly, telomere shorteningnounced telomere shortening was observed in cells sta-
bly expressing PinX1-C, even occurring at 4 PD (Figures is correlated with the crisis phenotype (Figures 3C, 3D,
6A–6C, and Supplemental Figure S2). In contrast, telo-6B and 6C). This is expected because 4 PD cells would
have passaged for24 PD given that 0 PD was defined meres were significantly elongated and more uniform in
the length in cells expressing PinX1AS, with an increasewhen single cell clones had expanded to the number
sufficient for characterization. In these PinX1-C- in TRF length to 7 kb and in the hybridization signal
at 4 PD (actually24 PD) (Figures 6B and 6C, and Supple-expressing cells, telomeres continued to shorten, with
TRF length reaching the minimal length (2.5 kb) at mental Figure S2). These results indicate that whereas
Cell
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Figure 5. Overexpression of PinX1 and PinX1-C Inhibits, Whereas Depletion Increases, Telomerase Activity
Stable HT1080 cell lines were harvested at 4 PD and telomerase-containing fractions prepared, followed by subjecting different amounts of
proteins to the TRAP assay. Telomerase products were stained with SYBR green (A) and semiquantified, with the average and standard
deviation from four experiments being present in (B). RNase was included in one assay. Arrows point to the 36 bp internal control (IC) for
PCR amplification.
depletion of endogenous PinX1 elongates telomeres, depletion of PinX1 increases telomerase activity in cells,
suggest that PinX1 and PinX1-C function as catalyticoverexpression of PinX1 and PinX1-C shortens telomeres,
with PinX1-C being much more potent than full-length inhibitors of telomerase. To test this possibility, we ex-
amined whether they interact with hTERT and whetherprotein.
they directly inhibit telomerase activity in vitro.
To examine the in vivo interaction, we first transientlyPinX1 and PinX1-C Do Not Induce Telomere
transfected HT1080 cell lines stably expressing PinX1Shortening or Crisis in Telomerase-Negative Cells
or PinX1-C with HA-hTERT and then subjected them toTo examine whether the effects of PinX1 on telomeres
immunoprecipitation. The purified anti-PinX1, but notand cell growth depend on telomerase activity, we stably
preimmune IgG, immunoprecipitated HA-hTERT fromexpressed PinX1 and PinX1-C in telomerase-negative
PinX1 and PinX1-C-expressing cells (Figure 7A), indicat-GM847 cells, which maintain very long but heteroge-
ing that PinX1 or PinX1-C forms stable complexes withneous telomeres by an alternative (ALT) mechanism
hTERT in cells. We next used GST pulldown experiments(Bryan et al., 1995). TRF length in these cells is not
to examine their in vitro interaction. GST-PinX1, but notaffected by dominant-negative telomerase (Hahn et al.,
GST, precipitated hTERT produced either in cells as an1999b), but rapidly shortened by fusion with other cell
HA-tagged protein or a GFP fusion protein by transienttypes, which is detected as soon as single cells expand
transfection or synthesized by in vitro transcription andto the number sufficient for measuring TRF length (20
translation (Figures 7C and 7D, data not shown). It ap-PD, defined as 0 PD here) (Perrem et al., 1999). However,
peared that both N- and C-terminal domains of PinX1even after 32 PD, telomeres in PinX1- or PinX1-C-
precipitated hTERT (Figures 7C and 7D). These resultsexpressing GM847 cells exhibited patterns similar to
indicate that PinX1 and its TID domain associate withthose in vector control cells, the characteristic of ALT
hTERT both in cells and in vitro.cells (Figure 6D). In addition, these cells did not enter
crisis (Figures 3E and 3F). These results indicate that To examine the effects on telomerase activity, te-
neither PinX1 nor PinX1-C induces telomere shortening lomerase-containing cell extracts were incubated with
or crisis in these telomerase-negative cells and further various GST-PinX1 proteins for 10 min before the TRAP
support that the ability of PinX1 and PinX1-C to shorten assay. Both GST-PinX1 and GST-PinX1-C potently in-
telomeres and induce crisis is via inhibiting telomerase. hibited telomerase activity in a concentration-depen-
dent manner (Figures 7E–7H), whereas neither GST nor
GST-PinX1-N had any significant effect (Figures 7E andPinX1 and PinX1-C Bind hTERT and Directly Inhibit
7H). Furthermore, His-PinX1 also potently inhibited te-Its Activity
lomerase (Figure 7H). Although at higher concentrations,The above results that PinX1-C almost completely inhib-
its and PinX1 reduces telomerase activity, whereas PinX1 and PinX1-C could also inhibit Taq polymerase
Figure 6. PinX1 Influences Telomere Length in Telomerase-Positive, but not in Telomerase-Negative Cells
Stable cell lines of HT1080 cells (A–C) or GM847 cells (D) were harvested at various PDs and genomic DNA was digested with HinfI and RsaI,
followed by Southern blot analysis using a TTAGGG repeat as a probe (A, B, and D). Prior to hybridization, the gels were stained with ethidium
bromide to insure equal loading of genomic DNA (lower panels). Average TRF length versus PD number in HT1080 cells was quantified using
ImageQuant and presented in (C).
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Figure 7. PinX1 and Pinx1-C Bind hTERT In Vivo and In Vitro, and Inhibit its Activity In Vitro
(A) In vivo interaction. PinX1 or PinX1-C stable HT1080 cells were transfected with HA-hTERT and immunoprecipitated with purified anti-
PinX1 antibodies or preimmune, followed by immunoblot with anti-HA (Top) or -PinX1 antibodies (Bottom).
(B). Commassie-stained SDS gel containing various recombinant PinX1 proteins.
(C and D) In vitro interaction. Glutathione beads containing GST or different GST-PinX1 proteins were incubated with cell extracts containing
HA-hTERT (C) or with 35S-hTERT synthesized by in vitro transcription and translation (D). After wash, the bound proteins were separated on
PinX1, a Novel Telomerase Inhibitor and a Putative Tumor Suppressor
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Figure 8. Depletion of Endogenous PinX1 Increases Tumorigenicity in Nude Mice
HT1080 cell lines stably expressing indicated PinX1 constructs or the vector were harvested at 8 PD and injected subcutaneously into NCr
outbred (A–C) or BALB/c inbred (C) athymic nude mice. Mice were monitored for the visual appearance of tumors at injection sites (A and B)
and tumors were harvested and weighed 2 months after injection (C).
(Figures 7E and 7F), they had no effect at all when ex- with the findings that PinX1 and PinX1-C induced crisis
(Figures 3 and 4). However, the most striking phenotypepressed in cells (Figure 5), demonstrating the specificity
of telomerase inhibition by PinX1 and PinX1-C. These was observed with cells expressing PinX1AS. As com-
pared with control vector cells, PinX1AS-expressing cellsresults indicate that PinX1 is a potent telomerase inhibi-
tor and the inhibitory domain is located at its C-terminal produced tumors at a higher frequency and also without
latency after injection (Figure 8A). The tumors grew more74 aa, which is designated the telomerase inhibitory
domain (TID). rapidly, with average tumor weight being26 times big-
ger than that of the controls (Figures 8B and 8C). Similar
results were also obtained when injected into BALB/cPinX1 Depletion Increases Tumorigenicity in Mice
The human PINX1 gene localizes to chromosome 8p23 inbred nude mice; five out of six mice injected with
PinX1AS-expressing cells produced tumors, whereas nobased on the human genome sequence (http://www.
ncbi.nlm.nih.gov/genemap99/map.cgi?CHR8) (Delou- tumor was detected in mice injected with PinX1 or
PinX1-C-expressing cells or control cells (Figure 8C).kas et al., 1998). Loss of heterozygosity (LOH) at 8p23
occurs at a high frequency in a number of human can- These results indicate that whereas PinX1 and PinX1-C
inhibit tumor growth, depletion of PinX1 increases tu-cers (Baffa et al., 2000; Bockmuhl et al., 2001; Emi et
al., 1992; Gustafson et al., 1996; Ishwad et al., 1999; morigenicity in nude mice and support that PinX1 is a
putative tumor suppressor.Muscheck et al., 2000; Perinchery et al., 1999; Sun et
al., 1999), suggesting that PinX1 may be a potential
tumor suppressor. To explore this possibility, we exam- Discussion
ined whether depletion of PinX1 function increases tu-
morigenicity of HT1080 cells in mice. In order to detect Here we describe characterization of PinX1, a novel pro-
tein interacting with Pin2/TRF1. Overexpression ofthe increase in tumorigenicity, we injected a relatively
low number of cells at 8 PD (1  106 cells/per site). At PinX1 and its TID inhibited telomerase activity, short-
ened telomeres and induced crisis with TID being more2 months after injection into NCr outbred nude mice,
tumors were visually identified at 60% of sites that were potent than the full-length protein, whereas depletion
of endogenous PinX1 significantly increased telomeraseinjected with control vector cells, although no tumor
was observed at sites injected with cells expressing activity and lengthened telomeres. Significantly, both
PinX1 and its TID domain bound hTERT in vivo and inPinX1 or PinX1-C (Figure 8). These results are consistent
SDS-containing gels, followed by detecting HA-hTERT by immunoblot with anti-HA antibody or 35S-hTERT by autoradiography.
(E–H) Potent inhibition of telomerase by PinX1 and PinX1-C. Different concentrations of GST or GST-PinX1 (E and H), GST-PinX1-C (F and
H), PinX1-N protein (G and H) or His-PinX1 (H) were incubated with telomerase extracts for 10 min before the TRAP assay. Arrows point to
the 36 bp internal control (IC) for PCR amplification.
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vitro, and also potently inhibited its activity in vitro. In tency in vitro. Because they are expressed at similar
levels, a likely possibility is that the full-length proteinContrast, neither PinX1 nor its TID induced telomere
shortening or crisis in telomerase-negative cells. There- may be subjected to endogenous regulation such as
posttranslational modifications to reduce its inhibitoryfore, distinct from other proteins that modulate telomere
length without affecting telomerase activity per se, activity. Alternatively, proteins that interact with PinX1
in cells may reduce the ability of its TID domain to bindPinX1 represents a novel class of proteins that can regu-
late telomerase activity directly. Interestingly, human and inhibit telomerase activity. One such protein could
be Pin2/TRF1, which binds PinX1 and colocalizes PinX1PINX1 is located at 8p23, a region with frequent loss of
heterozygosity in a number of human tumors. Moreover, in cells, although the biological significance of this inter-
action remains to be determined. The presence of PinX1depletion of endogenous PinX1 in HT1080 cells in-
creased their tumorigenicity, whereas overexpression homologous genes in other eukaryotes such as yeast
suggests its conservation. Interestingly, hTERT is alsoof PinX1 or PinX1-C inhibits their ability to form tumors
in mice. These results suggest that PinX1 is a putative rather conserved, especially in the catalytic site. If the
yeast PinX1 would function like the human protein,tumor suppressor.
PinX1 might provide a general mechanism for regulating
telomerase activity. In addition, since disruption of theIs PinX1 an Endogenous Telomerase Inhibitor?
yeast PinX1 ORF appears to be lethal, it may have otherThe following results (Table S1 at http://www.cell.com/
yet unidentified function.cgi/content/full/107/3/347/DC1) support that PinX1
functions as an endogenous telomerase inhibitor. First,
expressed PinX1 is a nuclear protein that is localized at Could PinX1 Be a Tumor Suppressor?
the nucleolus and at telomeres, the substrate for te- The chromosomal location of the PinX1 gene, 8p23 near
lomerase (Greider and Blackburn, 1985). Second, PinX1 the microsatellite maker D8S277, marks it as a candidate
and PinX1-C form stable complexes with hTERT both tumor suppressor. This region has been extensively in-
in vivo and in vitro. Third, PinX1 and its small TID domain vestigated due to its frequent loss of heterozygosity
directly inhibits telomerase activity with a high potency (LOH) in a number of human cancers, including liver,
in vitro, indicating that the domain in PinX1 responsible breast, prostate, colorectal, lung, head, and neck (Baffa
for the telomerase inhibition is located at its small C-ter- et al., 2000; Bockmuhl et al., 2001; Emi et al., 1992;
minal TID domain. Fourth, when overexpressed in te- Gustafson et al., 1996; Ishwad et al., 1999; Liao et al.,
lomerase-positive HT1080 cells, PinX1 significantly in- 2000; Muscheck et al., 2000; Perinchery et al., 1999;
hibits cellular telomerase activity and leads to progres- Sun et al., 1999). For example, in human hepatocellular
sive telomere shortening. Fifth, the TID domain of PinX1 carcinomas, about 40%–50% of tumors exhibit LOH
almost completely inhibits telomerase activity and is near the maker D8S277 and molecular analysis suggests
much more potent than PinX1 in shortening telomeres. the presence of tumor suppressor genes on chromo-
Sixth, although PinX1 and PinX1-C initially have no effect some 8p23. Indeed, the N-terminal 113 residues of PinX1
on cell growth rate, they eventually induce crisis, with are almost identical to a small 174 amino acid protein
their ability to affect cell growth being correlated with deduced by a putative liver tumor suppressor gene
their ability to inhibit telomerase activity and to shorten cloned by PCR (Liao et al., 2000), which was reported
telomeres. After crisis, some cells eventually recover while we were preparing our manuscript. This putative
and continue to divide with reactivation of telomerase cDNA contains a premature stop at 113 residue of PinX1
and elongation of telomeres (data not shown). Seventh, due to an internal deletion. Although it is unknown
neither PinX1 nor its TID induces telomere shortening whether this small protein is expressed in vivo, RT-PCR
or crisis in telomerase-negative cells. Eighth, depletion analysis using primers common for the PINX1 gene and
of endogenous PinX1 increases telomerase activity and the putative liver gene has shown that the transcript is
telomere length in vivo, indicating a critical role for the downregulated or absent in about 42% of hepatocellular
Pinx1 concentration in regulating telomerase activity in carcinoma cell lines (Liao et al., 2000). Furthermore, our
vivo. Finally, depletion of endogenous PinX1 increased preliminary immunostaining analysis revealed that
tumorigenicity of HT1080 cells, whereas overexpression PinX1 expression is significantly reduced or is not de-
of PinX1 or PinX1-C inhibits their ability to form tumors tectable in many human tumor samples including liver,
in nude mice. These results indicate that PinX1 is a prostate, colon, and lung carcinoma (X.Z.Z and K.P.L.
potent telomerase inhibitor and provides a novel and unpublished data). These results suggest that expres-
important in vivo route for regulation of telomerase ac- sion of the PINX1 gene may be reduced or absent in
tivity. many human cancer tissues.
The significance of reduced expression of PinX1 in
tumors is substantiated by our findings that depletion ofHow Does PinX1 Inhibit Telomerase Activity?
We do not yet know how PinX1 inhibits telomerase activ- PinX1 increases tumorigenicity of HT1080 cells, whereas
overexpression of PinX1 or PinX1-C inhibits their abilityity. Both PinX1 and TID domain bind hTERT and inhibit
its activity in vitro and in vivo, indicating that the TID to produce tumors in nude mice. Activation of te-
lomerase is a common and critical event for cellulardomain is sufficient to potently inhibit telomerase. It is
likely that the TID domain may interact with hTERT and transformation and this activation is important for trans-
formed cells to continue cell division. The fact that PinX1inhibit its activity. If this is the case, it would be of
great interest to determine why full-length PinX1 protein inhibits telomerase suggests that inactivation or down-
regulation of PinX1 may contribute to activation of te-appears less active in inhibiting telomerase activity than
the TID domain in cells, although they have similar po- lomerase in cancer cells. In addition, PinX1 might have
PinX1, a Novel Telomerase Inhibitor and a Putative Tumor Suppressor
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Telomerase and TRF Length Assaysother as yet unidentified functions that contribute to its
For assaying telomerase activity in cells, cells were lysed in a lysistumor suppressing function. Nevertheless, our results
buffer and telomerase-containing fraction was prepared, followedsuggest that PinX1 might be one of the long sought
by assaying the telomerase activity using the TRAP-eze telomerase
tumor suppressor genes located at chromosome 8p23. detection kit (Intergen), according to the manufacturer’s protocol.
We are performing experiments including detecting To examine the effects on telomerase activity in vitro, various PinX1
proteins were incubated with telomerase for 10 min at 4C beforePINX1 mutations in cancer and disrupting the PinX1
subjecting to telomerase extension. Telomerase products were sep-gene in mice to examine the possibility. Given its ability
arated on 10% polyacrylamide gels, which were stained with SYBRto inhibit telomerase, induce crisis, and inhibit tumor
Green. Telomerase activity was semiquantified by normalizing theformation in nude mice, PinX1 or its TID might be useful
band intensities of the characteristic 6 bp telomerase-specific lad-
for cancer therapy. der to that of the 36 bp internal standard using NIH image software
(Kim et al., 1994). TRF length was measured, as described (Counter
Experimental Procedures et al., 1992; Harley et al., 1990). Briefly, genomic DNA was isolated
and digested with HinfI and RsaI, separated on 0.7% agarose gels
Yeast Two-Hybrid Screen (2 g/lane). The gels were dried and hybridized with a telomeric
The yeast two-hybrid screen was carried out, as described (Lu et DNA probe and average TRF length was calculated by quantifying
al., 1996). Briefly, the Pin2 cDNA was fused to the GAL4 DNA binding the hybridization signals using ImageQuant.
domain and transformed into the Y190 yeast strain to establish
stable transformants. The stable strains were transformed again Tumorigenicity Assay
with a HeLa cDNA library fused to the GAL4 activation domain. The Stable HT1080 cell lines at 8 PD were harvested and washed twice
GenBank accession numbers for human and mouse PINX1 cDNAs in cold serum-free DMEM. Cells were resuspended in 0.25 ml of
are AY029161 and AF421879, respectively. cold serum-free DMEM, and the suspension was mixed with an
equal volume of cold Matrigel (Becton Dickinson). The cell suspen-
Expression and Purification of Recombinant Proteins sion was injected subcutaneously (0.5 ml per site, 1  106 cells at
To generate N-terminally GST- or His-PinX1 fusion proteins, cDNAs 8 PD) into 5- to 6-week-old NCr athymic nude mice (Taconic). Mice
encoding PinX1 and its mutants were subcloned into a pGEX or were observed weekly for the visual appearance of tumors at injec-
pET28a vector, respectively, and the resulting fusion proteins ex- tion sites and tumors were harvested and weighed 8 weeks after
pressed and purified by glutathione or Ni2-NTA agarose column, injection. The cells were also injected into BALB/c athymic nude
as described (Lu et al., 1999b; Zhou et al., 2000b). The same method mice (Taconic) using the same procedure without Matrigel.
is used to purify various GST-Pin2 proteins.
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